Key points

  • The mainstay of treatment for myeloma is to receive several drugs in combination
  • Through the course of their myeloma, patients may receive the same treatment more than once, particularly if they showed a good response to that treatment previously and did not progress whilst receiving the treatment or shortly thereafter
  • No treatment for myeloma is currently considered to be curative
  • Some patients will receive one or more autologous stem cell transplants
  • Patients may respond differently to the same treatment, despite being at the same disease stage
  • A patient’s age, any pre-existing medical conditions and personal preferences must all be taken into consideration in treatment decisions
  • Nurses play a crucial role in ensuring that patients and their families are kept informed about their treatment options throughout the different stages of their disease
  • Almost all treatments for myeloma bring side effects. You can read more about how nurses can help manage these side effects in Module 8 of this programme and in our Myeloma Nurse Guide series.
  • Quality of life should always be factored into treatment decisions and patients should feel able to discuss their concerns with their medical team, particularly during later lines of therapy
  • You can find more information on all drugs discussed here on Patient Information Hub.